Park Ha Biological Technology is trading at $2.38, up 6.49% from its October 16 close of $2.20; no specific cause for the pre-market gain has been established. - No confirmed October 19 company-specific announcement was found; recent headlines are older, including September class-action notices. - The move follows an after-hours rise on October 16, for which no clear catalyst was identified. - U.S. futures rebounded from the prior week’s tech sell-off, while biotech-sector weakness was also reported.